Skip to main content
Figure 4 | Molecular Cancer

Figure 4

From: Fusion of EML4 and ALK is associated with development of lung adenocarcinomas lacking EGFR and KRAS mutations and is correlated with ALK expression

Figure 4

Kaplan-Meier survival curve, stratified by ALK fusion status. Percent survival of patients with and without ALK fusions was plotted versus the number of months after surgery. Prior to the date of article submission, the ALK fusion-positive patients (n = 12) did not have enough events to determine the median overall survival, while the ALK fusion-negative patients (n = 101) had a median overall survival of 50.5 months. The hazard ratio for death in the ALK fusion-positive group was 0.54 (95% CI, 0.23-1.26). The log-rank (Mantel-Cox) test had a chi-squared value of 2.33 (P = 0.15).

Back to article page

Molecular Cancer

ISSN: 1476-4598